These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16086038)

  • 1. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.
    Gibson J
    Eye (Lond); 2005 Aug; 19(8):829-30. PubMed ID: 16086038
    [No Abstract]   [Full Text] [Related]  

  • 2. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia-1-year results of a prospective series.
    Lam DS; Liu DT; Fan DS; Lai WW; So SF; Chan WM
    Eye (Lond); 2005 Aug; 19(8):834-40. PubMed ID: 15375364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study.
    Pece A; Vadalà M; Isola V; Matranga D
    Am J Ophthalmol; 2007 Mar; 143(3):449-54. PubMed ID: 17317390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation in pathologic myopia.
    Gelisken F; Inhoffen W; Hermann A; Grisanti S; Bartz-Schmidt KU
    Graefes Arch Clin Exp Ophthalmol; 2004 Nov; 242(11):926-30. PubMed ID: 15258776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy (PDT) using verteporfin for juxtafoveal choroidal neovascularisation (CNV) in angioid streaks (AS) associated with pseudoxanthoma elasticum: 40 months results.
    Chung AK; Gauba V; Ghanchi FD
    Eye (Lond); 2006 May; 20(5):629-31. PubMed ID: 15920567
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
    Hariprasad SM; Shah GK
    Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia: long-term study.
    Pece A; Isola V; Vadalà M; Matranga D
    Retina; 2006 Sep; 26(7):746-51. PubMed ID: 16963846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.
    Degenring RF; Jonas JB
    Acta Ophthalmol Scand; 2005 Oct; 83(5):621. PubMed ID: 16188006
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of juxtafoveal and extrafoveal choroidal neovascularization in the era of photodynamic therapy with verteporfin.
    Jampol LM; Scott L
    Am J Ophthalmol; 2002 Jul; 134(1):99-101. PubMed ID: 12095815
    [No Abstract]   [Full Text] [Related]  

  • 10. Early neovascular bridging after photodynamic therapy of myopic choroidal neovascularization.
    Lanzetta P; Parodi MB; Ambesi-Impiombato M; Ravalico G; Bandello F
    Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):840-4. PubMed ID: 15221306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy with verteporfin for choroidal neovascularization complicating angioid streaks.
    Karadimas P; Bouzas EA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):78-80. PubMed ID: 14750772
    [No Abstract]   [Full Text] [Related]  

  • 12. Verteporfin in Photodynamic Therapy: report no. 5.
    Bandello F; Blinder K; Bressler NM; Brown AL; Miller JW; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Slakter JS; Soubrane G; Strong HA; Stur M;
    Ophthalmology; 2004 Nov; 111(11):2144. PubMed ID: 15522385
    [No Abstract]   [Full Text] [Related]  

  • 13. Verteporfin in Photodynamic Therapy (VIP) Study group.
    Ruiz-Oliva F; Cortés J
    Ophthalmology; 2002 Jun; 109(6):1043; author reply 1043-4. PubMed ID: 12045040
    [No Abstract]   [Full Text] [Related]  

  • 14. Twofold illumination photodynamic therapy scheme for subfoveal choroidal neovascularization in pathologic myopia: results from a randomized pilot study.
    Costa RA; Williams GA;
    Retina; 2006 Sep; 26(7):757-64. PubMed ID: 16963848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of photodynamic therapy in ophthalmology.
    Sivaprasad S; Hykin P
    Br J Hosp Med (Lond); 2006 Dec; 67(12):647-50. PubMed ID: 17328448
    [No Abstract]   [Full Text] [Related]  

  • 16. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
    Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
    Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
    Sharp DM; Lai S; Markey CM
    Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for choroidal neovascularization secondary to sympathetic ophthalmia.
    Kinge B; Syrdalen P; Björnsson OM
    Retina; 2005; 25(3):375-7. PubMed ID: 15805921
    [No Abstract]   [Full Text] [Related]  

  • 19. Verteporfin photodynamic therapy of choroidal neovascularization secondary to ocular toxoplasmosis.
    Wirthlin R; Song A; Song J; Rosenfeld PJ
    Arch Ophthalmol; 2006 May; 124(5):741-3. PubMed ID: 16682600
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'.
    Barnes RM; Gee L; Taylor S; Briggs MC; Harding SP
    Eye (Lond); 2004 Aug; 18(8):809-13. PubMed ID: 14963483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.